AQR Capital Management’s Coherus Oncology CHRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $2.04M | Buy |
1,206,046
+320,326
| +36% | +$569K | ﹤0.01% | 2331 |
|
|
2025
Q4 | $1.26M | Sell |
885,720
-17,317
| -2% | -$25.2K | ﹤0.01% | 2428 |
|
|
2025
Q3 | $1.48M | Buy |
903,037
+134,116
| +17% | +$149K | ﹤0.01% | 2183 |
|
|
2025
Q2 | $562K | Buy |
768,921
+100,956
| +15% | +$87.2K | ﹤0.01% | 2555 |
|
|
2025
Q1 | $539K | Sell |
667,965
-546,569
| -45% | -$629K | ﹤0.01% | 2389 |
|
|
2024
Q4 | $1.68M | Sell |
1,214,534
-305,177
| -20% | -$342K | ﹤0.01% | 1626 |
|
|
2024
Q3 | $1.58M | Buy |
1,519,711
+799,712
| +111% | +$1.1M | ﹤0.01% | 1607 |
|
|
2024
Q2 | $1.25M | Buy |
+719,999
| New | +$1.45M | ﹤0.01% | 1654 |
|
|
2024
Q1 | – | Sell |
-371,366
| Closed | -$1.24M | – | 2429 |
|
|
2023
Q4 | $1.24M | Buy |
371,366
+330,233
| +803% | +$884K | ﹤0.01% | 1526 |
|
|
2023
Q3 | $154K | Sell |
41,133
-2,083
| -5% | -$9.62K | ﹤0.01% | 2180 |
|
|
2023
Q2 | $185K | Sell |
43,216
-27,000
| -38% | -$159K | ﹤0.01% | 2087 |
|
|
2023
Q1 | $480K | Sell |
70,216
-14,776
| -17% | -$115K | ﹤0.01% | 1793 |
|
|
2022
Q4 | $673K | Buy |
84,992
+47,670
| +128% | +$367K | ﹤0.01% | 1707 |
|
|
2022
Q3 | $359K | Sell |
37,322
-8,560
| -19% | -$86.6K | ﹤0.01% | 1889 |
|
|
2022
Q2 | $332K | Sell |
45,882
-31,826
| -41% | -$277K | ﹤0.01% | 1829 |
|
|
2022
Q1 | $1M | Buy |
77,708
+60,442
| +350% | +$769K | ﹤0.01% | 1531 |
|
|
2021
Q4 | $276K | Sell |
17,266
-2,564
| -13% | -$44.8K | ﹤0.01% | 2006 |
|
|
2021
Q3 | $319K | Sell |
19,830
-7,177
| -27% | -$105K | ﹤0.01% | 2020 |
|
|
2021
Q2 | $374K | Sell |
27,007
-84,533
| -76% | -$1.2M | ﹤0.01% | 1984 |
|
|
2021
Q1 | $1.63M | Buy |
111,540
+16,187
| +17% | +$275K | ﹤0.01% | 1320 |
|
|
2020
Q4 | $1.66M | Sell |
95,353
-16,945
| -15% | -$302K | ﹤0.01% | 1261 |
|
|
2020
Q3 | $2.06M | Sell |
112,298
-107,796
| -49% | -$2.01M | ﹤0.01% | 1093 |
|
|
2020
Q2 | $3.93M | Buy |
220,094
+128,672
| +141% | +$2.18M | 0.01% | 879 |
|
|
2020
Q1 | $1.48M | Buy |
91,422
+54,237
| +146% | +$1M | ﹤0.01% | 1188 |
|
|
2019
Q4 | $670K | Buy |
37,185
+19,254
| +107% | +$355K | ﹤0.01% | 1655 |
|
|
2019
Q3 | $363K | Buy |
17,931
+3,567
| +25% | +$71.3K | ﹤0.01% | 1860 |
|
|
2019
Q2 | $317K | Sell |
14,364
-8,903
| -38% | -$155K | ﹤0.01% | 1868 |
|
|
2019
Q1 | $317K | Sell |
23,267
-16,158
| -41% | -$216K | ﹤0.01% | 1953 |
|
|
2018
Q4 | $357K | Buy |
+39,425
| New | +$456K | ﹤0.01% | 1897 |
|
|
2017
Q4 | – | Sell |
-26,915
| Closed | -$359K | – | 2226 |
|
|
2017
Q3 | $359K | Buy |
26,915
+13,015
| +94% | +$172K | ﹤0.01% | 2035 |
|
|
2017
Q2 | $199K | Sell |
13,900
-3,029
| -18% | -$58.3K | ﹤0.01% | 2130 |
|
|
2017
Q1 | $358K | Buy |
+16,929
| New | +$416K | ﹤0.01% | 1973 |
|
Other funds holding CHRS
VCM
SB
KKRC
CM
CWG